Report
Richard Williamson

Riber - Emerging from the shadow of coronavirus

While Riber’s H121 performance was depressed by the lack of MBE system orders during FY20, customer confidence appears to be returning. The resultant increase in order intake points to a much stronger second half, with management forecasting over €30.0m revenues and an operating income of €1.2m for the full year. We are upgrading our FY21 estimates, raising PBT by 27%, while leaving our FY22 estimates unchanged.
Underlying
Riber SA

Riber and its subsidiaries are engaged in the design, produce, sale and maintain molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. In addition to MBE systems, a comprehensive range of MBE related-components is also available. These equipments are essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, from new information technologies to Organic Light-Emitting Diode flat screens and new generation thin layer solar cells.

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Analysts
Richard Williamson

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch